Sientra Announces FDA-Clearance of Novel Portfinder™ Technology
17. Mai 2023 08:30 ET
|
Sientra, Inc.
IRVINE, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record First Quarter 2023 Operational Results
11. Mai 2023 16:02 ET
|
Sientra, Inc.
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Eleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX,...
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
01. Mai 2023 16:05 ET
|
Sientra, Inc.
IRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches
30. März 2023 16:02 ET
|
Sientra, Inc.
Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free...
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
20. März 2023 08:35 ET
|
Sientra, Inc.
IRVINE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer System
01. März 2023 08:32 ET
|
Sientra, Inc.
IRVINE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Announces 1-for-10 Reverse Stock Split
20. Januar 2023 09:25 ET
|
Sientra, Inc.
IRVINE, Calif., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
29. Dezember 2022 16:05 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced...
Sientra Expands Global Footprint With Regulatory Approval to Market Breast Implants in the United Arab Emirates
13. Dezember 2022 16:05 ET
|
Sientra, Inc.
IRVINE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record Third Quarter 2022 Financial Results
10. November 2022 16:05 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...